Glipizide
20 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
20
Total Reports
3
Deaths Reported
1500.0%
Death Rate
Active Ingredients
Glipizide
Administration Routes
UnknownOralTransdermal
Species Affected
Cat 12
Human 7
Dog 1
Most Affected Breeds
Domestic Shorthair 7
Unknown 7
Siamese 2
Domestic Mediumhair 2
Crossbred Canine/dog 1
Ragdoll 1
Most Reported Reactions
Ketosis 5
Lethargy (see also Central nervous system depression in Neurological) 4
Vomiting 3
Decreased appetite 3
Accidental exposure 3
Behavioural disorder NOS 2
Weight loss 2
Elevated alanine aminotransferase (ALT) 2
Rash 2
Anxiety 2
Seizure NOS 2
Death by euthanasia 2
Outcome Breakdown
Ongoing
7 (35.0%)
Outcome Unknown
6 (30.0%)
Recovered/Normal
3 (15.0%)
Euthanized
2 (10.0%)
Recovered with Sequela
1 (5.0%)
Died
1 (5.0%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.